Literature DB >> 9694899

The membrane proximal cytokine receptor domain of the human interleukin-6 receptor is sufficient for ligand binding but not for gp130 association.

S Ozbek1, J Grötzinger, B Krebs, M Fischer, A Wollmer, T Jostock, J Müllberg, S Rose-John.   

Abstract

Interleukin-6 (IL-6) belongs to the family of the "four-helix bundle" cytokines. The extracellular parts of their receptors consist of several Ig- and fibronectin type III-like domains. Characteristic of these receptors is a cytokine-binding module consisting of two such fibronectin domains defined by a set of four conserved cysteines and a tryptophan-serine-X-tryptophan-serine (WSXWS) sequence motif. On target cells, IL-6 binds to a specific IL-6 receptor (IL-6R), and the complex of IL-6.IL-6R associates with the signal transducing protein gp130. The IL-6R consists of three extracellular domains. The NH2-terminal Ig-like domain is not needed for ligand binding and signal initiation. Here we have investigated the properties and functional role of the third membrane proximal domain. The protein can be efficiently expressed in bacteria, and the refolded domain is shown to be sufficient for IL-6 binding. When complexed with IL-6, however, it fails to associate with the gp130 protein. Since the second and the third domain together with IL-6 can bind to gp130 and induce signaling, our data demonstrate the ligand binding function of the third domain and point to an important role of the second domain in complex formation with gp130 and signaling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694899     DOI: 10.1074/jbc.273.33.21374

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain.

Authors:  J N Varghese; R L Moritz; M-Z Lou; A Van Donkelaar; H Ji; N Ivancic; K M Branson; N E Hall; R J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

2.  A biosensor study indicating that entropy, electrostatics, and receptor glycosylation drive the binding interaction between interleukin-7 and its receptor.

Authors:  Scott T R Walsh
Journal:  Biochemistry       Date:  2010-09-15       Impact factor: 3.162

3.  Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex.

Authors:  Sabine R Quadt-Akabayov; Jordan H Chill; Rina Levy; Naama Kessler; Jacob Anglister
Journal:  Protein Sci       Date:  2006-09-25       Impact factor: 6.725

4.  Low expression of IL6R predicts poor prognosis for lung adenocarcinoma.

Authors:  Gaofeng Sun; Tianyi Wang; Muqi Shi; Hao Zhou; Jinjie Wang; Zhanghao Huang; Haijian Zhang; Jiahai Shi
Journal:  Ann Transl Med       Date:  2021-07

5.  A global method for fast simulations of molecular dynamics in multiscale agent-based models of biological tissues.

Authors:  Daniel Bergman; Randy F Sweis; Alexander T Pearson; Fereshteh Nazari; Trachette L Jackson
Journal:  iScience       Date:  2022-05-13

6.  NMR mapping of the IFNAR1-EC binding site on IFNalpha2 reveals allosteric changes in the IFNAR2-EC binding site.

Authors:  Sabine Ruth Akabayov; Zohar Biron; Peter Lamken; Jacob Piehler; Jacob Anglister
Journal:  Biochemistry       Date:  2010-02-02       Impact factor: 3.162

7.  Intermolecular interactions in a 44 kDa interferon-receptor complex detected by asymmetric reverse-protonation and two-dimensional NOESY.

Authors:  Ilona Nudelman; Sabine R Akabayov; Einat Schnur; Zohar Biron; Rina Levy; Yingqi Xu; Daiwen Yang; Jacob Anglister
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

8.  1H, 15N and 13C backbone assignment of the carboxyl terminal domain of the cytokine binding module of the interleukin-6 receptor.

Authors:  Andreas Schwantner; Andrew J Dingley; Suat Ozbek; Oliver Hecht; Stefan Rose-John; Joachim Grötzinger
Journal:  J Biomol NMR       Date:  2004-07       Impact factor: 2.835

9.  A mathematical model for IL-6-mediated, stem cell driven tumor growth and targeted treatment.

Authors:  Fereshteh Nazari; Alexander T Pearson; Jacques Eduardo Nör; Trachette L Jackson
Journal:  PLoS Comput Biol       Date:  2018-01-19       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.